Dimethylamine

Dimethylamine

SCHEMBL5459104

C=C1CSc2c(C(=O)OC)ccc(Cl)c2C1=O.CNC

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.36
ABL1 P00519 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
NR4A2 P43354 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MITF O75030 1/20 0.33
TSHR P16473 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
LMNA P02545 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
SERPINH1 P50454 1/20 0.32
GAA P10253 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
FLT1 P17948 1/20 0.32
FLT4 P35916 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5459098 0.77 KMT2A (0.35) USP2ABL1ALDH1A1MAPTNR4A2
SCHEMBL5459096 0.77 KMT2A (0.35) USP2ABL1ALDH1A1MAPTNR4A2
SCHEMBL5450432 0.74 ABL1 (0.37) USP2ABL1ALDH1A1MAPTNR4A2
SCHEMBL7418272 0.62 ABL1 (0.47) ABL1ALDH1A1MAPTNR4A2MITF
SCHEMBL27362505 0.61 ABL1 (0.50) ABL1ALDH1A1MAPTNR4A2L3MBTL1
SCHEMBL8026148 0.61 PTGS2 (0.47) ABL1ALDH1A1MAPTNR4A2L3MBTL1
SCHEMBL7980013 0.61 MAPT (0.38) ABL1ALDH1A1MAPTMITFTSHR
SCHEMBL523584 0.60 ABL1 (0.57) ABL1ALDH1A1MAPTNR4A2L3MBTL1
SCHEMBL14699891 0.60 ABL1 (0.49) ABL1ALDH1A1MAPTNR4A2L3MBTL1
SCHEMBL10610948 0.60 ABL1 (0.49) ABL1ALDH1A1MAPTNR4A2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197393-A1 TRICYCLIC BENZOYLPYRAZOLE DERIVATIVES WITSCHEL MATTHIAS 2007-08-23 US disclosed
US-7115545-B1 Tricyclic benzoylpyrazole derivatives used as a herbicide BASF AKTIENGESELLSCHAFT (DE) 2006-10-03 US disclosed
US-6583089-B1 Pre- and postemergence herbicides such as (5,5-dimethyl-1,3-dioxocyclohex-2yl)(6-methoxy-3a,4-dihydro-3H -chromeno(4,3c) isoxazolin-9-yl)methanone, formed by acylation and rearranging in the presence of catalysts BASF AKTIENGESELLSCHAFT (DE) 2003-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197393-A1 TRICYCLIC BENZOYLPYRAZOLE DERIVATIVES CBR3, CBR1, KAT8 USP2 2322/4885ABL1 1344/4885ALDH1A1 4069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.